ℹ️
🇬🇧
Search
Search for publications relevant for "riociguat"
riociguat
Publication
Class
Person
Publication
Programmes
Export current view
publication
Riociguat, an oral soluble guanylate cyclase stimulator, in the treatment of pulmonary hypertension
2016 |
First Faculty of Medicine
publication
Riociguat - the first proven effective pharmacotherapy in patients with unresectable and residual chronic thromboembolic pulmonary hypertension
2014 |
First Faculty of Medicine
publication
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension
2013 |
First Faculty of Medicine
publication
Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE
2020 |
First Faculty of Medicine
publication
Sensitive CE-MS method for monitoring of riociguat and desmethylriociguat levels in human serum
2020 |
First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
publication
Development of a CE-MS method for the study of riociguat and metabolite M1 in pharmaceutical analysis
2019 |
First Faculty of Medicine, Faculty of Science
publication
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
2017 |
Publication without faculty affiliation
publication
The pharmacology treatment of a chronic thromboembolic pulmonary hypertension - the case report
2019 |
First Faculty of Medicine
publication
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
2023 |
First Faculty of Medicine
publication
Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension
2022 |
First Faculty of Medicine, Faculty of Social Sciences
publication
The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry
2021 |
First Faculty of Medicine
publication
Chronic thromboembolic pulmonary hypertension
2016 |
First Faculty of Medicine
publication
A severe right heart failure as a result of chronic thromboembolic pulmonary hypertension
2019 |
First Faculty of Medicine
publication
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
2017 |
First Faculty of Medicine
publication
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)
2015 |
First Faculty of Medicine
publication
Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice
2020 |
First Faculty of Medicine, Faculty of Science
publication
Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)
2020 |
First Faculty of Medicine
publication
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
2021 |
First Faculty of Medicine
publication
Surgical treatment of chronic thromboembolic pulmonary hypertension
2019 |
First Faculty of Medicine
publication
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
2017 |
First Faculty of Medicine
publication
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
2020 |
First Faculty of Medicine
publication
Chronická tromboembolická plicní hypertenze - závažná komplikace akutní plicní embolie
2016 |
First Faculty of Medicine
publication
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
2021 |
First Faculty of Medicine
publication
Acute hemodynamic effects of Riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1)
2014 |
First Faculty of Medicine
publication
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial
2016 |
First Faculty of Medicine
publication
Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial
2016 |
First Faculty of Medicine
publication
Plicní hypertenze - doporučení ESC/ČKS
2016 |
First Faculty of Medicine
publication
Chronic thromboembolic pulmonary hypertension: role of medical therapy
2013 |
First Faculty of Medicine
publication
Operability assessment in CTEPH: Lessons from the CHEST-1 study
2016 |
First Faculty of Medicine